Skip to main content

Table 1 Baseline characteristics of sepsis patients stratified by ABE quartiles

From: Association between alactic base excess on mortality in sepsis patients: a retrospective observational study

 

Overall (N = 17,099)

Q1 (N = 4270)

Q2 (N = 4018)

Q3 (N = 4518)

Q4 (N = 4292)

P

Age, years

67.82 (56.80, 78.04)

66.76 (54.93, 77.99)

68.13 (56.94, 77.94)

67.42 (57.11, 77.14)

68.96 (58.17, 79.07)

0.003

Male, %

10,210 (59.7)

2230 (54.6)

2460 (61.2)

2951 (65.3)

2469 (57.5)

 < 0.001

White, %

11,449 (67.0)

2742 (64.2)

2696 (67.1)

3131 (69.3)

2880 (67.1)

 < 0.001

Body mass index, kg/m2

27.79 (24.14, 32.46)

27.49 (23.87, 32.11)

27.76 (24.24, 32.22)

28.00 (24.39, 32.28)

28.00 (24.03, 33.08)

0.139

Vital signs

 Heart rate, bpm

87 (77, 103)

93 (80, 109)

87 (76, 101)

85 (76, 98)

87 (77, 102)

 < 0.001

 SBP, mmHg

117 (103, 135)

115 (101, 133)

117 (103, 134)

117 (104, 134)

120 (106, 137)

 < 0.001

 DBP, mmHg

64 (54, 75)

63 (53, 75)

63 (53, 75)

64 (55, 75)

65 (55, 76)

0.207

 Respiratory rate, bpm

18 (15, 23)

20 (16, 24)

18 (15, 22)

17 (14, 22)

18 (15, 23)

 < 0.001

 Oxygen saturation, %

99 (96, 100)

98 (95, 100)

99 (96, 100)

99 (96, 100)

99 (96, 100)

 < 0.001

 SOFA

3.00 (2.00, 5.00)

4.00 (2.00, 6.00)

3.00 (2.00, 5.00)

3.00 (2.00, 4.00)

3.00 (2.00, 4.00)

 < 0.001

Comorbidities, n (%)

 ARFA

5965 (34.9)

1837 (43.0)

1340 (33.3)

1295 (28.7)

1493 (34.8)

 < 0.001

 SAE

12,903 (75.5)

3378 (79.1)

2949 (73.4)

3249 (71.9)

3327 (77.5)

 < 0.001

 Sepsis shock

3226 (18.9)

1451 (34.0)

691 (17.2)

548 (12.1)

536 (12.5)

 < 0.001

 Acute kidney injury

     

 < 0.001

 Stage I

2256 (13.2)

409 (9.6)

550 (13.7)

698 (15.4)

599 (14.0)

 

 Stage II

5171 (30.2)

1228 (28.8)

1249 (31.1)

1380 (30.5)

1314 (30.6)

 

 Stage III

2008 (11.7)

870 (20.4)

404 (10.1)

334 (7.4)

400 (9.3)

 

 Myocardial infarction

3328 (19.5)

899 (31.1)

808 (20.1)

881 (19.5)

740 (17.2)

 < 0.001

 CHF

5284 (30.9)

1285 (30.1)

1153 (28.7)

1271 (28.1)

1575 (36.7)

 < 0.001

 PVD

2246 (13.1)

568 (13.3)

551 (13.7)

635 (14.1)

492 (13.1)

0.002

 CVA

2476 (14.5)

530 (12.4)

605 (15.1)

722 (16.0)

619 (14.4)

 < 0.001

 CPD

4718 (27.6)

1101 (25.8)

1076 (26.8)

1143 (25.3)

1398 (32.6)

 < 0.001

 Hepatic disease

2611 (15.3)

901 (21.1)

562 (14.0)

551 (12.2)

597 (13.9)

 < 0.001

 Malignant cancer

2480 (14.5)

684 (16.0)

596 (14.8)

574 (12.7)

626 (14.6)

 < 0.001

 Diabetes mellitus

5262 (30.8)

1345 (31.5)

1172 (29.2)

1347 (29.8)

1398 (32.6)

0.002

Laboratory results

 ABE, mmol/L

1.20 (− 1.40, 3.20)

 − 4.00 (− 6.40, − 2.60)

0.20 (− 0.60, 0.80)

2.00 (1.60, 2.50)

5.10 (4.00, 7.20)

 < 0.001

 BE, mmol/L

 − 1.00 (− 4.00, 1.00)

 − 7.00 (− 10.00, − 5.00)

 − 2.00 (− 3.00, − 1.00)

0.00 (0.00, 1.00)

3.00 (2.00, 5.00)

 < 0.001

 Lactate, mmol/L

1.80 (1.20, 2.80)

2.10 (1.30, 3.50)

1.70 (1.10, 2.70)

1.80 (1.40, 2.50)

1.80 (1.20, 2.80)

 < 0.001

 Anion gap, mmol/L

14.00 (12.00, 17.00)

16.00 (13.00, 20.00)

14.00 (11.00, 17.00)

13.00 (11.00, 16.00)

13.00 (11.00, 16.00)

 < 0.001

 Glucose, mg/dL

137.00 (111.00, 173.00)

140.00 (110.00, 187.00)

136.00 (111.00, 170.00)

135.00 (112.00, 167.00)

135.00 (111.00, 171.00)

 < 0.001

 Bicarbonate, mmol/L

22.00 (20.00, 25.00)

18.00 (16.00, 20.00)

22.00 (20.00, 24.00)

23.00 (22.00, 25.00)

26.00 (23.00, 29.00)

 < 0.001

 BUN, mg/dL

20.00 (14.00, 33.00)

27.00 (17.00, 48.00)

20.00 (14.00, 30.00)

17.00 (13.00, 26.00)

19.00 (13.00, 30.00)

 < 0.001

 Calcium, mg/dL

8.10 (7.70, 8.60)

7.80 (7.30, 8.40)

8.10 (7.70, 8.60)

8.20 (7.80, 8.60)

8.40 (7.90, 8.80)

 < 0.001

 Chloride, mmol/L

106.00 (101.00, 110.00)

107.00 (103.00, 111.00)

107.00 (102.00, 110.00)

106.00 (102.00, 110.00)

103.00 (98.00, 108.00)

 < 0.001

 Sodium, mmol/L

139.00 (136.00, 141.00)

138.00 (125.00, 141.00)

139.00 (136.00, 141.00)

139.00 (136.00, 141.00)

139.00 (137.00, 142.00)

0.001

 Potassium, mmol/L

4.20 (3.80, 4.60)

4.30 (3.80, 4.90)

4.20 (3.80, 4.60)

4.10 (3.80, 4.50)

4.00 (3.60, 4.50)

 < 0.001

 Phosphorus, mg/dL

3.50 (2.90, 4.40)

4.00 (3.10, 5.20)

3.50 (2.90, 4.40)

3.40 (2.80, 4.10)

3.40 (2.80. 4.10)

 < 0.001

 eGFR, mL/min/1.73m2

72.77 (43.25, 102.20)

46.58 (26.11, 77.67)

73.09 (46.13, 101.46)

83.85 (57.92, 106.55)

81.96 (53.38, 110.10)

 < 0.001

 PaCO2, %

41.00 (35.00, 47.00)

39.00 (33.00, 46.00)

41.00 (35.00, 46.00)

41.00 (36.00, 46.00)

42.00 (37.00, 50.00)

 < 0.001

 Potential of hydrogen

7.31 (7.38, 7.43)

7.29 (7.21, 7.34)

7.36 (7.32 7.41)

7.40 (7.36, 7.44)

7.42 (7.38, 7.47)

 < 0.001

Interventions, %

 RRT

691 (4.0)

335 (7.8)

115 (2.9)

99 (2.2)

142 (3.3)

 < 0.001

 Mechanical ventilation

10,639 (62.2)

2749 (64.4)

2509 (62.4)

2740 (25.8)

2641 (61.5)

0.003

Medications, %

 Vasopressors

9605 (56.2)

2725 (63.8)

2276 (56.6)

2506 (55.5)

2098 (48.9)

 < 0.001

 Corticosteroids

1185 (6.9)

411 (9.6)

268 (6.7)

239 (5.3)

267 (6.2)

 < 0.001

 Antitotic drugs

14,950 (87.4)

3756 (88.0)

3500 (87.1)

3979 (88.1)

3715 (86.5)

0.099

 Furosemide

5399 (31.6)

927 (21.7)

1186 (29.5)

1637 (36.2)

1649 (38.4)

 < 0.001

 Fluid output, L

2.34 (1.39, 3.48)

1.96 (1.03, 3.23)

2.40 (1.49, 3.50)

2.55 (1.62, 3.60)

2.37 (1.47, 3.49)

 < 0.001

 Fluid input, L

1.88 (9.25, 3.09)

2.37 (1.22, 3.90)

1.95 (1.00, 3.06)

1.74 (0.87, 2.77)

1.60 (0.73, 2.61)

 < 0.001

  1. Q1 (ABE < − 1.40), Q2 (− 1.40 ≤ ABE < 1.20), Q3 (1.20 ≤ ABE < 3.20), and Q4 (ABE ≥ 3.20)
  2. ABE alactic base excess; AFRA acute respiratory failure; BUN blood urea nitrogen; CHF congestive heart failure; CPD chronic pulmonary disease; CVA cerebrovascular disease; DBP diastolic blood pressure; eGFR estimated glomerular filtration rate; PaCO2 partial pressure of carbon dioxide; PVD peripheral vascular disease; RRT renal replacement therapy; SAE sepsis associated encephalopathy; SBP systolic blood pressure; SOFA Sequential Organ Failure Assessment